FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Greene

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Physiology

Disorders

Cell Transformation, Neoplastic

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Miao Feng; Mark I Greene; Shi Jiao; Liangliang Kong; Zhubing Shi; Wenjia Wang; Liang Xu; Yao Cong; Zhanyu Ding; Zhaocai Zhou
Structural and biochemical studies of RIG-I antiviral signaling.
Guoping Deng; Bin LI; Yasuhiro Nagai; Yan Xiao; Hongtao Zhang; Zhaocai Zhou; Mark I Greene
Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.
E. Aaron Runkle; Qiang Wang; Shiaw-Lin Wu; Hongtao Zhang; Zhaocai Zhou; Zhiqiang Zhu; Zheng Cai; Barry L Karger; Donald M O'Rourke; Mark I Greene
Reversion of the ErbB malignant phenotype and the DNA damage response.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Greene (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Miao Feng; Mark I Greene; Shi Jiao; Liangliang Kong; Zhubing Shi; Wenjia Wang; Liang Xu; Yao Cong; Zhanyu Ding; Zhaocai Zhou
Structural and biochemical studies of RIG-I antiviral signaling.
Protein & cell 2013;4(2):142-54.
2012: Guoping Deng; Bin LI; Yasuhiro Nagai; Yan Xiao; Hongtao Zhang; Zhaocai Zhou; Mark I Greene
Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.
Experimental and molecular pathology 2012;93(3):334-8.
2012: E. Aaron Runkle; Qiang Wang; Shiaw-Lin Wu; Hongtao Zhang; Zhaocai Zhou; Zhiqiang Zhu; Zheng Cai; Barry L Karger; Donald M O'Rourke; Mark I Greene
Reversion of the ErbB malignant phenotype and the DNA damage response.
Experimental and molecular pathology 2012;93(3):324-33.
2012: Wenjia Wang; Yun Zhao; Cuicui Chen; Mark I Greene; Shi Jiao; Guoguang Liu; Zhubing Shi; Huizhen Wang; Qiang Wang; Zhaocai Zhou
Structural insights into SUN-KASH complexes across the nuclear envelope.
Cell research 2012;22(10):1440-52.
2012: Xiaomin Song; Qiang Wang; Andrew D Wells; Shiaw-Lin Wu; Yan Xiao; Chen Xu; Hongtao Zhang; Zhaocai Zhou; Alan Berezov; Zheng Cai; Chunxia Chen; Yayi Gao; Wayne W Hancock; Barry L Karger; Bin LI; Zhiyuan Li; Yujie Liu; Mark I Greene
Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function.
Cell reports 2012;1(6):665-75.
2012: Alan Berezov; Zheng Cai; Xin Cheng; J A Freudenberg; Mark I Greene; Ramachandran Murali; T Thompson; Hongtao Zhang; Q Wang
Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin.
Oncogene 2012;31(15):1938-48.
2012: Zhaocai Zhou; Shiaw-Lin Wu; Marla Rosanne Yee; Hongtao Zhang; Alan Berezov; Zheng Cai; Xiulian Du; Mark I Greene; Barry L Karger; Takako Mizuno; Ramachandran Murali; Xiaomin Song; Emi Suzuki; Qiang Wang
Structure of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in nuclear envelope.
The Journal of biological chemistry 2012;287(8):5317-26.
2011: Datta E Ponde; ZiFen Su; Alan Berezov; Hongtao Zhang; Abbas Alavi; Mark I Greene; Ramachandran Murali
Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent.
Bioorganic & medicinal chemistry letters 2011;21(8):2550-3.
2010: Zheng Cai; Hongtao Zhang; Jing Liu; Alan Berezov; Ramachandran Murali; Qiang Wang; Mark I Greene
Targeting erbB receptors.
Seminars in cell & developmental biology 2010;21(9):961-6.
2010: Mark I Greene; Herman Waldmann
Regulation of the immune response.
Current opinion in immunology 2010;22(5):549-51.
2010: Yan Xiao; Bin LI; Zhaocai Zhou; Wayne W Hancock; Hongtao Zhang; Mark I Greene
Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function.
Current opinion in immunology 2010;22(5):583-91.
2010: Qingdu Liu; Yoshihiko Hirohashi; Xiulian Du; Mark I Greene; Qiang Wang
Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancer.
Experimental and molecular pathology 2010;88(2):225-33.
2010: Geng Zhang; Hongtao Zhang; Qiang Wang; Priti Lal; Ann M Carroll; Margarita de la Llera-Moya; Xiaowei Xu; Mark I Greene
Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(2):732-7.
2009: Qingguo Ruan; Vasumathi Kameswaran; Yukiko Tone; Li Li; Hsiou-Chi Liou; Mark I Greene; Masahide Tone; Youhai H Chen
Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome.
Immunity 2009;31(6):932-40.
2009: Sandra J Saouaf; Bin LI; Geng Zhang; Yuan Shen; Narumi Furuuchi; Wayne W Hancock; Mark I Greene
Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.
Experimental and molecular pathology 2009;87(2):99-104.
2009: Jaclyn A Freudenberg; Qiang Wang; Makoto Katsumata; Jeffrey A Drebin; Izumi Nagatomo; Mark I Greene
The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.
Experimental and molecular pathology 2009;87(1):1-11.
2009: Zhaocai Zhou; Xiaomin Song; Alan Berezov; Bin LI; Mark I Greene
Structural aspects of the FOXP3 regulatory complex as an immunopharmacological target.
International immunopharmacology 2009;9(5):518-20.
2008: Arabinda Samanta; Bin LI; Xiaomin Song; Kathryn Bembas; Geng Zhang; Makoto Katsumata; Sandra J Saouaf; Qiang Wang; Wayne W Hancock; Yuan Shen; Mark I Greene
TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(37):14023-7.
2008: Jaclyn A Freudenberg; Kathryn Bembas; Mark I Greene; Hongtao Zhang
Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood.
Methods (San Diego, Calif.) 2008;46(1):33-8.
2008: Dalia Hope Levine; P Peter Ghoroghchian; Jaclyn Freudenberg; Geng Zhang; Michael J Therien; Mark I Greene; Daniel A Hammer; Ramachandran Murali
Polymersomes: a new multi-functional tool for cancer diagnosis and therapy.
Methods (San Diego, Calif.) 2008;46(1):25-32.
2008: Zheng Cai; Mark I Greene; Alan Berezov
Modulation of biomolecular interactions with complex-binding small molecules.
Methods (San Diego, Calif.) 2008;46(1):39-46.
2008: Qiang Wang; Mark I Greene
Mechanisms of resistance to ErbB-targeted cancer therapeutics.
The Journal of clinical investigation 2008;118(7):2389-92.
2008: Zheng Cai; G Zhang; Z Zhou; K Bembas; Jeffrey A Drebin; Mark I Greene; Hongtao Zhang
Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes.
Oncogene 2008;27(27):3870-4.
2008: Zhaocai Zhou; Xiaomin Song; Alan Berezov; Geng Zhang; Yanjing Li; Hongtao Zhang; Ramachandran Murali; Bin LI; Mark I Greene
Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(14):5465-70.
2008: Yukiko Tone; Keiji Furuuchi; Yoshitsugu Kojima; Mark L Tykocinski; Mark I Greene; Masahide Tone
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer.
Nature immunology 2008;9(2):194-202.
2008: Zhaocai Zhou; Yukiko Tone; Xiaomin Song; Keiji Furuuchi; James D Lear; Herman Waldmann; Masahide Tone; Mark I Greene; Ramachandran Murali
Structural basis for ligand-mediated mouse GITR activation.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(2):641-5.
2008: Bin LI; Mark I Greene
Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppression.
Immunology 2008;123(1):17-9.
2007: Kathryn T Iacono; Amy L Brown; Mark I Greene; Sandra J Saouaf
CD147 immunoglobulin superfamily receptor function and role in pathology.
Experimental and molecular pathology 2007;83(3):283-95.
2007: Bin LI; Sandra J Saouaf; Arabinda Samanta; Yuan Shen; Wayne W Hancock; Mark I Greene
Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppression.
Current opinion in immunology 2007;19(5):583-8.
2007: Hongtao Zhang; Alan Berezov; Qiang Wang; Geng Zhang; Jeffrey A Drebin; Ramachandran Murali; Mark I Greene
ErbB receptors: from oncogenes to targeted cancer therapies.
The Journal of clinical investigation 2007;117(8):2051-8.
2007: Bin LI; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Patrick Brennan; Talal A Chatila; Giovanna Roncador; Alison H Banham; James L Riley; Qiang Wang; Yuan Shen; Sandra J Saouaf; Mark I Greene
FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease.
International immunology 2007;19(7):825-35.
2007: Bin LI; Mark I Greene
FOXP3 actively represses transcription by recruiting the HAT/HDAC complex.
Cell cycle (Georgetown, Tex.) 2007;6(12):1432-6.
2007: Bin LI; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Kathryn Bembas; Ran Tao; Samik Basu; James L Riley; Wayne W Hancock; Yuan Shen; Sandra J Saouaf; Mark I Greene
FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(11):4571-6.
2007: Keiji Furuuchi; Alan Berezov; Toru Kumagai; Mark I Greene
Targeted antireceptor therapy with monoclonal antibodies leads to the formation of inactivated tetrameric forms of ErbB receptors.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(2):1021-9.
2006: K Masuda; Mark Richter; X Song; Alan Berezov; K Masuda; Ramachandran Murali; Mark I Greene; Hongtao Zhang
AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu.
Oncogene 2006;25(59):7740-6.
2006: Xiulian Du; Qiang Wang; Yoshihiko Hirohashi; Mark I Greene
DIPA, which can localize to the centrosome, associates with p78/MCRS1/MSP58 and acts as a repressor of gene transcription.
Experimental and molecular pathology 2006;81(3):184-90.
2006: Yoshihiko Hirohashi; Qing Wang; Qingdu Liu; Bin LI; Xiulian Du; Hongtao Zhang; Keiji Furuuchi; K Masuda; N Sato; Mark I Greene
Centrosomal proteins Nde1 and Su48 form a complex regulated by phosphorylation.
Oncogene 2006;25(45):6048-55.
2006: Qiang Wang; Xiulian Du; Zheng Cai; Mark I Greene
Characterization of the structures involved in localization of the SUN proteins to the nuclear envelope and the centrosome.
DNA and cell biology 2006;25(10):554-62.
2006: Yoshihiko Hirohashi; Qing Wang; Qingdu Liu; Xiulian Du; Hongtao Zhang; N Sato; Mark I Greene
p78/MCRS1 forms a complex with centrosomal protein Nde1 and is essential for cell viability.
Oncogene 2006;25(35):4937-46.
2006: Bin LI; Arabinda Samanta; Xiaomin Song; Keiji Furuuchi; Kathryn T Iacono; Sarah Kennedy; Makoto Katsumata; Sandra J Saouaf; Mark I Greene
FOXP3 ensembles in T-cell regulation.
Immunological reviews 2006;212():99-113.
2006: Patrick J Brennan; Sandra J Saouaf; Steven J Van Dyken; Jamey D Marth; Bin LI; Avinash Bhandoola; Mark I Greene
Sialylation regulates peripheral tolerance in CD4+ T cells.
International immunology 2006;18(5):627-35.
2006: Qiang Wang; Xiulian Du; Judy Meinkoth; Yoshihiko Hirohashi; Hongtao Zhang; Qingdu Liu; Mark Richter; Mark I Greene
Characterization of Su48, a centrosome protein essential for cell division.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(17):6512-7.
2006: Hongtao Zhang; Xin Cheng; Mark Richter; Mark I Greene
A sensitive and high-throughput assay to detect low-abundance proteins in serum.
Nature medicine 2006;12(4):473-7.
2006: Makoto Katsumata; Jeffrey A Drebin; Mark I Greene
Trastuzumab in breast cancer.
The New England journal of medicine 2006;354(6):640-4; author reply 640-4.
2006: Alan Berezov; Mark I Greene
Towards comprehensive characterization of HER2 overexpression.
Molecular systems biology 2006;2():55.
2005: Huiwu Zhao; Qiang Wang; Hongtao Zhang; Qingdu Liu; Xiulian Du; Mark Richter; Mark I Greene
UXT is a novel centrosomal protein essential for cell viability.
Molecular biology of the cell 2005;16(12):5857-65.
2005: Qiang Wang; Mark I Greene
EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway.
Experimental and molecular pathology 2005;79(2):100-7.
2005: Jinqiu Chen; Henry C Tseng; Marc A Dichter; Hongtao Zhang; Mark I Greene
Differential localization of ErbB receptor ensembles influences their signaling in hippocampal neurons.
DNA and cell biology 2005;24(9):553-62.
2005: Ramachandran Murali; Xin Cheng; Alan Berezov; Xiulian Du; Arne Schön; Ernesto Freire; Xiaowei Xu; Youhai H Chen; Mark I Greene
Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(31):10970-5.
2004: Haresha Samaranayake; James C Saunders; Mark I Greene; Dhasakumar Navaratnam
Ca(2+) and K(+) (BK) channels in chick hair cells are clustered and colocalized with apical-basal and tonotopic gradients.
The Journal of physiology 2004;560(Pt 1):13-20.
2004: Qiang Wang; Yoshihiko Hirohashi; Keiji Furuuchi; Huiwu Zhao; Qingdu Liu; Hongtao Zhang; Ramachandran Murali; Alan Berezov; Xiulian Du; Bin LI; Mark I Greene
The centrosome in normal and transformed cells.
DNA and cell biology 2004;23(8):475-89.
2004: Akihiro Hasegawa; Xin Cheng; Kiichi Kajino; Alan Berezov; Kaoru Murata; Toshinori Nakayama; Hideo Yagita; Ramachandran Murali; Mark I Greene
Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(17):6599-604.
2003: Toru Kumagai; Makoto Katsumata; Akihiro Hasegawa; Keiji Furuuchi; Toshiki Funakoshi; Ichiro Kawase; Mark I Greene
Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(16):9220-5.
2003: Hongtao Zhang; Mark Richter; Mark I Greene
Therapeutic monoclonal antibodies for the ErbB family of receptor tyrosine kinases.
Cancer biology & therapy 2003;2(4 Suppl 1):S122-6.
2003: Ramachandran Murali; Q Liu; X Cheng; Alan Berezov; M Richter; K Furuchi; Mark I Greene; H Zhang
Antibody like peptidomimetics as large scale immunodetection probes.
Cellular and molecular biology (Noisy-le-Grand, France) 2003;49(2):209-16.
2003: Sandra J Saouaf; Patrick J Brennan; Yuan Shen; Mark I Greene
Mechanisms of peripheral immune tolerance: conversion of the immune to the unresponsive phenotype.
Immunologic research 2003;28(3):193-9.
2003: Alan Berezov; Mark I Greene; Ramachandran Murali
Structure-based approaches to inhibition of erbB receptors with peptide mimetics.
Immunologic research 2003;27(2-3):303-8.
2003: Patrick J Brennan; Sandra J Saouaf; Mark I Greene; Yuan Shen
Anergy and suppression as coexistent mechanisms for the maintenance of peripheral T cell tolerance.
Immunologic research 2003;27(2-3):295-302.
2003: Xin Cheng; Masa Kinosaki; Ramachandran Murali; Mark I Greene
The TNF receptor superfamily: role in immune inflammation and bone formation.
Immunologic research 2003;27(2-3):287-94.
2002: Alan Berezov; Jinqiu Chen; Qingdu Liu; Hong-Tao Zhang; Mark I Greene; Ramachandran Murali
Disabling receptor ensembles with rationally designed interface peptidomimetics.
The Journal of biological chemistry 2002;277(31):28330-9.
2002: B Li; H Zhao; Q Liu; Ramachandran Murali; Mark I Greene; Hongtao Zhang
Deoxycholate-based Method to screen phage display clones for uninterrupted open reading frames.
BioTechniques 2002;33(2):294-6.
2002: David A Cowan; Denise M Gay; Bert M Bieler; Huizhen Zhao; Atsuko Yoshino; James G Davis; Mary M Tomayko; Ramachandran Murali; Mark I Greene; Michael S Marks
Characterization of mouse tGolgin-1 (golgin-245/trans-golgi p230/256 kD golgin) and its upregulation during oligodendrocyte development.
DNA and cell biology 2002;21(7):505-17.
2001: C J Wu; Donald M O'Rourke; G S Feng; Gibbes R Johnson; Qing Wang; Mark I Greene
The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Oncogene 2001;20(42):6018-25.
2001: Qing Wang; Hongtao Zhang; S Guerrette; J Chen; Anthony Mazurek; Teresa Wilson; Artur Slupianek; Tomasz Skorski; Richard Fishel; Mark I Greene
Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1.
Oncogene 2001;20(34):4640-9.
2001: Alan Berezov; Hong-Tao Zhang; Mark I Greene; Ramachandran Murali
Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis.
Journal of medicinal chemistry 2001;44(16):2565-74.
2001: T Matsunaga; James G Davis; Mark I Greene
Adult rat otic placode-derived neurons and sensory epithelium express all four erbB receptors: a role in regulating vestibular ganglion neuron viability.
DNA and cell biology 2001;20(6):307-19.
2001: HT Zhang; Janet Estee Kacharmina; Kevin Miyashiro; Mark I Greene; james eberwine
Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(10):5497-502.
2001: Toru Kumagai; James G Davis; T Horie; Donald M O'Rourke; Mark I Greene
The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(10):5526-31.
2000: Qing Wang; Hongtao Zhang; Richard Fishel; Mark I Greene
BRCA1 and cell signaling.
Oncogene 2000;19(53):6152-8.
2000: P J Brennan; T Kumagai; Alan Berezov; Ramachandran Murali; Mark I Greene; T Kumogai
HER2/neu: mechanisms of dimerization/oligomerization.
Oncogene 2000;19(53):6093-101.
2000: H Maeda; S Fujimoto; Mark I Greene
Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vbeta 8.1 transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(24):13257-62.
2000: C J Wu; Z Chen; A Ullrich; Mark I Greene; Donald M O'Rourke
Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
Oncogene 2000;19(35):3999-4010.
2000: Hongtao Zhang; Qing Wang; Kiichi Kajino; Mark I Greene
VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells.
DNA and cell biology 2000;19(5):253-63.
2000: T Matsunaga; Mark I Greene; James G Davis
Distinct expression patterns of eph receptors and ephrins relate to the structural organization of the adult rat peripheral vestibular system.
The European journal of neuroscience 2000;12(5):1599-616.
2000: BW Park; Hong-Tao Zhang; C Wu; Alan Berezov; X Zhang; R Dua; Qing Wang; Gary D Kao; Donald M O'Rourke; Mark I Greene; Ramachandran Murali
Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo.
Nature biotechnology 2000;18(2):194-8.
1999: Joachim Roland; Alan Berezov; Mark I Greene; Ramachandran Murali; Dominique Piatier-Tonneau; Christian Devaux; Laurence Briant
The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expression.
DNA and cell biology 1999;18(11):819-28.
1999: H Zhang; Qiang Wang; Kathleen T Montone; J E Peavey; Jeffrey A Drebin; Mark I Greene; Ramachandran Murali
Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies.
Experimental and molecular pathology 1999;67(1):15-25.
1999: BW Park; Donald M O'Rourke; Qing Wang; James G Davis; A Post; X Qian; Mark I Greene
Induction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(11):6434-8.
1999: X Qian; Donald M O'Rourke; Z Fei; Hong-Tao Zhang; C C Kao; Mark I Greene
Domain-specific interactions between the p185(neu) and epidermal growth factor receptor kinases determine differential signaling outcomes.
The Journal of biological chemistry 1999;274(2):574-83.
1998: Norman C Peterson; Mark I Greene
Bacterial expression and characterization of recombinant biologically active anti-tyrosine kinase receptor antibody forms.
DNA and cell biology 1998;17(12):1031-40.
1998: Qing Wang; Hongtao Zhang; Kiichi Kajino; Mark I Greene
BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells.
Oncogene 1998;17(15):1939-48.
1998: Donald M O'Rourke; Gary D Kao; N Singh; BW Park; Ruth J Muschel; C J Wu; Mark I Greene
Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(18):10842-7.
1998: HT Zhang; Donald M O'Rourke; Huizhen Zhao; Ramachandran Murali; Y Mikami; James G Davis; Mark I Greene; X Qian
Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
Oncogene 1998;16(22):2835-42.
1998: Curtis C Maier; Avinash Bhandoola; W Borden; K Yui; K Hayakawa; Mark I Greene
Unique molecular surface features of in vivo tolerized T cells.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(8):4499-503.
1998: Donald M O'Rourke; E J Nute; James G Davis; C Wu; A Lee; Ramachandran Murali; HT Zhang; X Qian; C C Kao; Mark I Greene
Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
Oncogene 1998;16(9):1197-207.
1998: Donald M O'Rourke; Mark I Greene
Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.
Immunologic research 1998;17(1-2):179-89.
1998: Ramachandran Murali; Mark I Greene
Structure-based design of immunologically active therapeutic peptides.
Immunologic research 1998;17(1-2):163-9.
1998: Curtis C Maier; Mark I Greene
Biochemical features of anergic T cells.
Immunologic research 1998;17(1-2):133-40.
1998: Kiichi Kajino; Y Kajino; Mark I Greene
Fas- and perforin-independent mechanism of cytotoxic T lymphocyte.
Immunologic research 1998;17(1-2):89-93.
1997: X Qian; Donald M O'Rourke; Jeffrey A Drebin; Huizhen Zhao; Qing Wang; Mark I Greene
Identification of p185neu sequences required for monoclonal antibody- or ligand-mediated receptor signal attenuation.
DNA and cell biology 1997;16(12):1395-405.
1997: W Takasaki; Y Kajino; Kiichi Kajino; Ramachandran Murali; Mark I Greene
Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor.
Nature biotechnology 1997;15(12):1266-70.
1997: Laurence Briant; N Signoret; Muriel Gaubin; Véronique Robert-Hebmann; X Zhang; Ramachandran Murali; Mark I Greene; Dominique Piatier-Tonneau; Christian Devaux
Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4.
The Journal of biological chemistry 1997;272(31):19441-50.
1997: HT Zhang; X Zhang; H Z Zhao; Y Kajino; Barbara L Weber; James G Davis; Qing Wang; Donald M O'Rourke; H B Zhang; Kiichi Kajino; Mark I Greene
Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells.
Oncogene 1997;14(24):2863-9.
1997: Donald M O'Rourke; X Zhang; Mark I Greene
Principles of receptor-based inhibition of erbB family receptor kinases: prospects for new therapies for human cancers.
Proceedings of the Association of American Physicians 1997;109(3):209-19.
1997: Donald M O'Rourke; X Qian; HT Zhang; James G Davis; E Nute; J Meinkoth; Mark I Greene
Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):3250-5.
1997: S Ichimiya; James G Davis; Donald M O'Rourke; Makoto Katsumata; Mark I Greene
Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury.
DNA and cell biology 1997;16(3):311-21.
1997: X Zhang; Muriel Gaubin; Laurence Briant; V Srikantan; Ramachandran Murali; U Saragovi; David Weiner; Christian Devaux; Monica Autiero; Dominique Piatier-Tonneau; Mark I Greene
Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
Nature biotechnology 1997;15(2):150-4.
1997: James G Davis; F R Burns; Dhasakumar Navaratnam; A M Lee; S Ichimiya; John C Oberholtzer; Mark I Greene
Identification of a structural constituent and one possible site of postembryonic formation of a teleost otolithic membrane.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):707-12.
1996: X Qian; Donald M O'Rourke; H Zhao; Mark I Greene
Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.
Oncogene 1996;13(10):2149-57.
1996: A M Lee; D Navaratnam; S Ichimiya; Mark I Greene; James G Davis
Cloning of m-ehk2 from the murine inner ear, an eph family receptor tyrosine kinase expressed in the developing and adult cochlea.
DNA and cell biology 1996;15(10):817-25.
1996: Bee-Cheng Sim; L Zerva; Mark I Greene; Nicholas R J Gascoigne
Control of MHC restriction by TCR Valpha CDR1 and CDR2.
Science (New York, N.Y.) 1996;273(5277):963-6.
1996: Ramachandran Murali; P J Brennan; Thomas Kieber-Emmons; Mark I Greene
Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(13):6252-7.
1996: X Zhang; Dominique Piatier-Tonneau; C Auffray; Ramachandran Murali; A Mahapatra; F Zhang; C C Maier; H Uri Saragovi; Mark I Greene
Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation.
Nature biotechnology 1996;14(4):472-5.
1996: N Rebai; Guillermina Almazan; L Wei; Mark I Greene; H Uri Saragovi
A p65/p95 neural surface receptor is expressed at the S-G2 phase of the cell cycle and defines distinct populations.
The European journal of neuroscience 1996;8(2):273-81.
1996: W C Dougall; X Qian; M J Miller; Mark I Greene
Association of signaling proteins with a nonmitogenic heterodimeric complex composed of epidermal growth factor receptor and kinase-inactive p185c-neu.
DNA and cell biology 1996;15(1):31-40.
1995: Anna Stieber; Y Chen; Jacqueline O Gonatas; W Dougall; X Qian; D O'Rourke; A Samanta; Mark I Greene; Nicholas K Gonatas
Identification of a 140 kDa protein of rat presynaptic terminal membranes encompassing the active zones.
Brain research 1995;700(1-2):261-70.
1995: A Samanta; X Qian; Mark I Greene
Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
DNA and cell biology 1995;14(11):921-30.
1995: James G Davis; John C Oberholtzer; F R Burns; A M Lee; J Saunders; james eberwine; Mark I Greene
Use of the teleost saccule to identify genes involved in inner ear function.
DNA and cell biology 1995;14(10):833-9.
1995: H Uri Saragovi; Avinash Bhandoola; M M Lemercier; G K Akbar; Mark I Greene
A receptor that subserves reovirus binding can inhibit lymphocyte proliferation triggered by mitogenic signals.
DNA and cell biology 1995;14(8):653-64.
1995: A Samanta; Mark I Greene
A kinase associated with chromatin that can be activated by ligand-p185c-Neu or epidermal growth factor-receptor interactions.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(14):6582-6.
1995: M Katsumata; T Okudaira; A Samanta; Douglas P Clark; J A Drebin; P Jolicoeur; Mark I Greene
Prevention of breast tumour development in vivo by downregulation of the p185neu receptor.
Nature medicine 1995;1(7):644-8.
1995: James G Davis; John C Oberholtzer; F R Burns; Mark I Greene
Molecular cloning and characterization of an inner ear-specific structural protein.
Science (New York, N.Y.) 1995;267(5200):1031-4.
1995: X Qian; W C Dougall; Z Fei; Mark I Greene
Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation.
Oncogene 1995;10(1):211-9.
1994: Norman C Peterson; Mark I Greene
Considerations in the design and production of small anti-receptor antibody forms: optimizing gains while reducing size.
Therapeutic immunology 1994;1(5):289-95.
1994: W C Dougall; Norman C Peterson; Mark I Greene
Antibody-structure-based design of pharmacological agents.
Trends in biotechnology 1994;12(9):372-9.
1994: W C Dougall; X Qian; Norman C Peterson; M J Miller; A Samanta; Mark I Greene
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
Oncogene 1994;9(8):2109-23.
1994: Avinash Bhandoola; H Bassiri; James F Markmann; K Yui; Y Hashimoto; Mark I Greene
Delayed allograft rejection by T cell receptor V beta 8.1 transgenic mice peripherally tolerized to Mls-1.
European journal of immunology 1994;24(7):1710-3.
1994: X Qian; W C Dougall; M E Hellman; Mark I Greene
Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
Oncogene 1994;9(5):1507-14.
1994: A Samanta; C M LeVea; W C Dougall; X Qian; Mark I Greene
Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(5):1711-5.
1994: X Qian; C M LeVea; J K Freeman; W C Dougall; Mark I Greene
Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(4):1500-4.
1994: V I Brown; N Shah; R Smith; M Hellman; Leonard Jarett; Y Mikami; E Cohen; X Qian; Mark I Greene
Demonstration by two-color flow cytometry that tyrosine kinase activity is required for down-modulation of the oncogenic neu receptor.
DNA and cell biology 1994;13(2):193-209.
1994: Avinash Bhandoola; K Yui; Richard Siegel; L Zerva; Mark I Greene
Gld and lpr mice: single gene mutant models for failed self tolerance.
International reviews of immunology 1994;11(3):231-44.
1994: W C Dougall; Mark I Greene
Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with the neu/c-erbB-2 protein.
Cell biophysics 1994;24-25():209-18.
1993: Avinash Bhandoola; E A Cho; K Yui; H Uri Saragovi; Mark I Greene; H Quill
Reduced CD3-mediated protein tyrosine phosphorylation in anergic CD4+ and CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(5):2355-67.
1993: W C Dougall; X Qian; Mark I Greene
Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.
Journal of cellular biochemistry 1993;53(1):61-73.
1993: J A Cohen; L A Baggott; Carmelo Romano; M Arai; T E Southerling; L H Young; C A Kozak; P B Molinoff; Mark I Greene
Characterization of a mouse beta 1-adrenergic receptor genomic clone.
DNA and cell biology 1993;12(6):537-47.
1993: S Komori; M Katsumata; Mark I Greene; K Yui
Frequent deletion of the transgene in T cell receptor beta chain transgenic mice.
International immunology 1993;5(2):161-7.
1993: G J Sauvé; H Uri Saragovi; Mark I Greene
Reovirus receptors.
Advances in virus research 1993;42():325-41.
1993: C M LeVea; J N Myers; W C Dougall; X Qian; Mark I Greene
A structural and kinetic comparison of proto-oncogenic and oncogenic neu holo-receptors expressed in insect cells.
Receptor 1993;3(4):293-309.
1992: M Katsumata; Richard Siegel; D C Louie; T Miyashita; Y Tsujimoto; Peter C Nowell; Mark I Greene; John C Reed
Differential effects of Bcl-2 on T and B cells in transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(23):11376-80.
1992: Rebecca Taub; Mark I Greene
Functional validation of ligand mimicry by anti-receptor antibodies: structural and therapeutic implications.
Biochemistry 1992;31(33):7431-5.
1992: Y Mikami; James G Davis; K Dobashi; W C Dougall; J N Myers; V I Brown; Mark I Greene
Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(16):7335-9.
1992: Richard Siegel; M Katsumata; T Miyashita; D C Louie; Mark I Greene; John C Reed
Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(15):7003-7.
1992: K Yui; Avinash Bhandoola; M Z Radic; S Komori; M Katsumata; Mark I Greene
Inhibition of abnormal T cell development and autoimmunity in gld mice by transgenic T cell receptor beta chain.
European journal of immunology 1992;22(7):1693-700.
1992: H Uri Saragovi; Mark I Greene; R A Chrusciel; M Kahn
Loops and secondary structure mimetics: development and applications in basic science and rational drug design.
Bio/technology (Nature Publishing Company) 1992;10(7):773-8.
1992: S Chen; R A Chrusciel; H Nakanishi; A Raktabutr; Michael E Johnson; A Sato; D Weiner; J Hoxie; H Uri Saragovi; Mark I Greene
Design and synthesis of a CD4 beta-turn mimetic that inhibits human immunodeficiency virus envelope glycoprotein gp120 binding and infection of human lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(13):5872-6.
1992: X L Quian; S J Decker; Mark I Greene
p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(4):1330-4.
1992: K Yui; M Katsumata; S Komori; L Gill-Morse; Mark I Greene
Response of V beta 8.1+ T cell clones to self Mls-1a: implications for the origin of autoreactive T cells.
International immunology 1992;4(2):125-33.
1992: William V Williams; David B Weiner; M A Borofsky; Don Rubin; K Yui; Mark I Greene
Modulation of T cell responses with MHC-derived peptides.
Immunologic research 1992;11(1):11-23.
1992: K Yui; Mark I Greene
CD4-CD8+ T-cell receptor-alpha beta+ major histocompatibility complex class-II-specific T-cell clones isolated from aged athymic mice.
Immunologic research 1992;11(1):3-10.
1992: J N Myers; C M LeVea; J E Smith; R G Kallen; L Tung; Mark I Greene
Expression, purification, and characterization of Bacneu. A soluble protein tyrosine kinase domain encoded by the neu-oncogene.
Receptor 1992;2(1):1-16.
1992: H C Maguire; M E Hellman; Mark I Greene; I-Tien Yeh
Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast.
Pathobiology : journal of immunopathology, molecular and cellular biology 1992;60(3):117-21.
1992: J A Cohen; Robert Sergott; William V Williams; S J Hill; M J Brown; Mark I Greene
In vivo modulation of oligodendrocyte function by an anti-receptor antibody.
Pathobiology : journal of immunopathology, molecular and cellular biology 1992;60(3):151-6.
1991: K Dobashi; James G Davis; Y Mikami; J K Freeman; J Hamuro; Mark I Greene
Characterization of a neu/c-erbB-2 protein-specific activating factor.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(19):8582-6.
1991: James G Davis; J Hamuro; C Y Shim; A Samanta; Mark I Greene; K Dobashi
Isolation and characterization of a neu protein-specific activating factor from human ATL-2 cell conditioned medium.
Biochemical and biophysical research communications 1991;179(3):1536-42.
1991: H Uri Saragovi; D Fitzpatrick; A Raktabutr; H Nakanishi; M Kahn; Mark I Greene
Design and synthesis of a mimetic from an antibody complementarity-determining region.
Science (New York, N.Y.) 1991;253(5021):792-5.
1991: V I Brown; Mark I Greene
Molecular and cellular mechanisms of receptor-mediated endocytosis.
DNA and cell biology 1991;10(6):399-409.
1991: William V Williams; Thomas Kieber-Emmons; David B Weiner; Don Rubin; Mark I Greene
Contact residues and predicted structure of the reovirus type 3-receptor interaction.
The Journal of biological chemistry 1991;266(14):9241-50.
1991: William V Williams; Thomas Kieber-Emmons; J VonFeldt; Mark I Greene; David B Weiner
Design of bioactive peptides based on antibody hypervariable region structures. Development of conformationally constrained and dimeric peptides with enhanced affinity.
The Journal of biological chemistry 1991;266(8):5182-90.
1991: J A Cohen; William V Williams; Herbert Geller; Mark I Greene
Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(4):1266-70.
1991: T M Williams; David B Weiner; Mark I Greene; H C Maguire
Expression of c-erbB-2 in human pancreatic adenocarcinomas.
Pathobiology : journal of immunopathology, molecular and cellular biology 1991;59(1):46-52.
1990: Richard Siegel; M Katsumata; S Komori; S Wadsworth; L Gill-Morse; S Jerrold-Jones; Avinash Bhandoola; Mark I Greene; K Yui
Mechanisms of autoimmunity in the context of T-cell tolerance: insights from natural and transgenic animal model systems.
Immunological reviews 1990;118():165-92.
1990: K Yui; S Komori; M Katsumata; R M Siegel; Mark I Greene
Self-reactive T cells can escape clonal deletion in T-cell receptor V beta 8.1 transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(18):7135-9.
1990: William V Williams; David B Weiner; Thomas Kieber-Emmons; Mark I Greene
Antibody geometry and form: three-dimensional relationships between anti-idiotypic antibodies and external antigens.
Trends in biotechnology 1990;8(9):256-63.
1990: J A Kern; D A Schwartz; J E Nordberg; David B Weiner; Mark I Greene; L Torney; Robert A Robinson
p185neu expression in human lung adenocarcinomas predicts shortened survival.
Cancer research 1990;50(16):5184-7.
1990: R F Lodato; H C Maguire; Mark I Greene; David B Weiner; Virginia A LiVolsi
Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1990;3(4):449-54.
1990: J A Cohen; William V Williams; David B Weiner; Herbert Geller; Mark I Greene
Ligand binding to the cell surface receptor for reovirus type 3 stimulates galactocerebroside expression by developing oligodendrocytes.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(13):4922-6.
1990: T Wada; X L Qian; Mark I Greene
Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.
Cell 1990;61(7):1339-47.
1990: R M Siegel; K Yui; D E Tenenholz; R Kubo; Mark I Greene
Inhibition of T cell development in thymic organ culture: implications for the mechanism of action of cyclosporin A.
European journal of immunology 1990;20(4):753-7.
1990: S Wadsworth; K Yui; R M Siegel; D E Tenenholz; J A Hirsch; Mark I Greene
Origin and selection of peripheral CD4-CD8- T cells bearing alpha/beta T cell antigen receptors in autoimmune gld mice.
European journal of immunology 1990;20(4):723-30.
1990: T Wada; J N Myers; Y Kokai; V I Brown; J Hamuro; C M LeVea; Mark I Greene
Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
Oncogene 1990;5(4):489-95.
1990: David B Weiner; J Nordberg; R Robinson; Peter C Nowell; Adi F Gazdar; Mark I Greene; William V Williams; J A Cohen; J A Kern
Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung.
Cancer research 1990;50(2):421-5.
1990: David B Weiner; K Hubner; William V Williams; Mark I Greene
Species tropism of HIV-1 infectivity of interspecific cell hybridomas implies non-CD4 structures are required for cell entry.
Cancer detection and prevention 1990;14(3):317-20.
1990: M L Kelsten; M S Berger; H C Maguire; D A Chianese; M E Hellman; David B Weiner; Mark I Greene
Analysis of c-erbB-2 protein expression in conjunction with DNA content using multiparameter flow cytometry.
Cytometry 1990;11(4):522-32.
1990: M Sugimoto; A H Sharpe; Y Sato; Mark I Greene; B N Fields
Reovirus transport--studies using lymphocytosis promoting factor.
Pathobiology : journal of immunopathology, molecular and cellular biology 1990;58(4):185-92.
1990: William V Williams; H Robert Guy; J A Cohen; David B Weiner; Mark I Greene
Structure and regulation of internal image idiotypes.
Chemical immunology 1990;48():185-208.
1990: S Komori; R M Siegel; K Yui; M Katsumata; Mark I Greene
T-cell receptor and autoimmune disease.
Immunologic research 1990;9(4):245-64.
1990: H C Maguire; Mark I Greene
Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.
Pathobiology : journal of immunopathology, molecular and cellular biology 1990;58(6):297-303.
1989: David B Weiner; Y Kokai; T Wada; J A Cohen; William V Williams; Mark I Greene
Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
Oncogene 1989;4(10):1175-83.
1989: Carmelo Romano; William V Williams; D J Fischberg; N Cocero; David B Weiner; Mark I Greene; P B Molinoff
Subtype-selective immunoprecipitation of the beta 2-adrenergic receptor.
Journal of neurochemistry 1989;53(2):362-9.
1989: Y Kokai; J N Myers; T Wada; V I Brown; C M LeVea; James G Davis; K Dobashi; Mark I Greene
Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.
Cell 1989;58(2):287-92.
1989: William V Williams; D A Moss; Thomas Kieber-Emmons; J A Cohen; J N Myers; David B Weiner; Mark I Greene
Development of biologically active peptides based on antibody structure.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(14):5537-41.
1989: William V Williams; S D London; David B Weiner; S Wadsworth; J A Berzofsky; F Robey; Don Rubin; Mark I Greene
Immune response to a molecularly defined internal image idiotope.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(12):4392-400.
1989: H C Maguire; C Jaworsky; J A Cohen; M Hellman; David B Weiner; Mark I Greene
Distribution of neu (c-erbB-2) protein in human skin.
The Journal of investigative dermatology 1989;92(6):786-90.
1989: David B Weiner; J Liu; J A Cohen; William V Williams; Mark I Greene
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
Nature 1989;339(6221):230-1.
1989: H C Maguire; Mark I Greene
The neu (c-erbB-2) oncogene.
Seminars in oncology 1989;16(2):148-55.
1989: S Wadsworth; K Yui; Mark I Greene
Major histocompatibility complex class I-specific cytolytic T cells, derived from gld mice, lacking Thy-1, CD4, and CD8.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(3):1018-22.
1989: William V Williams; David B Weiner; Mark I Greene
Molecular analysis of primary T cell involvement in the idiotypic network utilizing immunoglobulin-derived peptides.
The Year in immunology 1989;6():152-61.
1989: J N Myers; Y Kokai; J A Cohen; Mark I Greene
Monoclonal antibodies to oncogene encoded proteins. Immunologic modulation of cell growth, differentiation, and function.
The Year in immunology 1989;5():178-94.
1989: S Wadsworth; K Yui; A Yellen; Mark I Greene
Thy-1, CD4 and CD8 in T cell development.
The Year in immunology 1989;4():59-73.
1989: J A Cohen; David B Weiner; K F More; Y Kokai; William V Williams; H C Maguire; V A LiVolsi; Mark I Greene
Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract.
Oncogene 1989;4(1):81-8.
1989: Glen N Gaulton; Mark I Greene
Inhibition of cellular DNA synthesis by reovirus occurs through a receptor-linked signaling pathway that is mimicked by antiidiotypic, antireceptor antibody.
The Journal of experimental medicine 1989;169(1):197-211.
1989: William V Williams; H Robert Guy; David B Weiner; Mark I Greene
Three dimensional structure of a functional internal image.
Viral immunology 1989;2(4):239-46.
1988: David B Weiner; William V Williams; R M Siegel; S Jerrold-Jones; Mark I Greene
Molecular characterization of suppressor T cells.
Transplantation proceedings 1988;20(6):1151-3.
1988: William V Williams; H Robert Guy; J A Cohen; David B Weiner; Mark I Greene
Molecular and immunologic analyses of a functional internal image formed by an anti-receptor antibody.
Annales de l'Institut Pasteur. Immunology 1988;139(6):659-75.
1988: J A Cohen; William V Williams; Mark I Greene
Molecular aspects of reovirus-host cell interaction.
Microbiological sciences 1988;5(9):265-70.
1988: William V Williams; H Robert Guy; Don Rubin; F Robey; J N Myers; Thomas Kieber-Emmons; David B Weiner; Mark I Greene
Sequences of the cell-attachment sites of reovirus type 3 and its anti-idiotypic/antireceptor antibody: modeling of their three-dimensional structures.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(17):6488-92.
1988: K Yui; S Wadsworth; A Yellen; Y Hashimoto; Y Kokai; Mark I Greene
Molecular and functional properties of novel T cell subsets in C3H-gld/gld and nude mice. Implications for thymic and extrathymic maturation.
Immunological reviews 1988;104():121-55.
1988: David B Weiner; J Liu; N Hanna; J A Bluestone; J E Coligan; William V Williams; Mark I Greene
CD3-associated heterodimeric polypeptides on suppressor hybridomas define biologically active inhibitory cells.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(16):6077-81.
1988: Y Kokai; K Dobashi; David B Weiner; J N Myers; Peter C Nowell; Mark I Greene
Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(15):5389-93.
1988: J A Drebin; V C Link; Mark I Greene
Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.
Oncogene 1988;2(4):387-94.
1988: J A Drebin; V C Link; Mark I Greene
Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo.
Oncogene 1988;2(3):273-7.
1988: J A Cohen; Robert Sergott; Herbert Geller; M J Brown; Mark I Greene
Mammalian reovirus receptor expression by oligodendrocytes.
Annals of the New York Academy of Sciences 1988;540():445-8.
1988: K Yui; Y Hashimoto; Mark I Greene
T cell receptors of autoimmune mice: functional and molecular analysis of novel T cell subsets in C3H-gld/gld mice.
Immunologic research 1988;7(2):173-88.
1988: William V Williams; David B Weiner; S Wadsworth; Mark I Greene
The antigen-major histocompatibility complex-T cell receptor interaction. A structural analysis.
Immunologic research 1988;7(4):339-50.
1988: Y Kokai; T Wada; J N Myers; V I Brown; K Dobashi; J Cohen; J Hamuro; David B Weiner; Mark I Greene
The role of the neu oncogene product in cell transformation and normal development.
Princess Takamatsu symposia 1988;19():45-57.
1988: J Liu; M S Co; Mark I Greene
Reovirus type 3 and [125I]-iodocyanopindolol bind to distinct domains on the beta-adrenergic like receptor.
Immunologic research 1988;7(3):232-8.
1987: Y Kokai; J A Cohen; J A Drebin; Mark I Greene
Stage- and tissue-specific expression of the neu oncogene in rat development.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(23):8498-501.
1987: Mark I Greene; Y Kokai; Glen N Gaulton; Marianne Powell; H Geller; J A Cohen
Receptor systems in tissues of the nervous system.
Immunological reviews 1987;100():153-84.
1987: K Yui; Y Hashimoto; S Wadsworth; Mark I Greene
Characterization of Lyt-2-, L3T4- class I-specific cytolytic clones in C3H-gld/gld mice. Implications for functions of accessory molecules and programmed development.
The Journal of experimental medicine 1987;166(4):1026-40.
1987: Mark I Greene; M S Co
Shared structural features of an internal image bearing monoclonal anti-idiotype and the external antigen.
Monographs in allergy 1987;22():120-5.
1986: J A Drebin; V C Link; Robert A. Weinberg; Mark I Greene
Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(23):9129-33.
1986: J A Drebin; V C Link; D F Stern; Robert A. Weinberg; Mark I Greene
Development of monoclonal antibodies reactive with the product of the neu oncogene.
Symposium on Fundamental Cancer Research 1986;38():277-89.
1986: G N Gaulton; Mark I Greene
Anti-idiotypic antibodies of reovirus as biochemical and immunological mimics.
International reviews of immunology 1986;1(1):79-90.
1985: J A Drebin; V C Link; D F Stern; Robert A. Weinberg; Mark I Greene
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.
Cell 1985;41(3):697-706.
1984: J A Drebin; D F Stern; V C Link; Robert A. Weinberg; Mark I Greene
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene.
Nature 1984;312(5994):545-8.
1984: A L Schechter; D F Stern; L Vaidyanathan; S J Decker; J A Drebin; Mark I Greene; Robert A. Weinberg
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.
Nature 1984;312(5994):513-6.